THE CONTENT OF THIS PAGE IS OPEN ONLY TO IFSO MEMBERS. TO WATCH THE FULL VIDEOS PLEASE LOG IN IN THE MEMBERS' AREA
IF YOU FORGOT YOUR CREDENTIALS TO LOG IN PLEASE CONTACT info@ifso.com
ClosePharmacologic Management of Obesity Before and After Bariatric Surgery: Current Evidence
- 1Pre Questionnaire
- 2Video
- 3Post Questionnaire
Results: out of 3
Which of the following is true about using obesity medications before metabolic and bariatric surgery?
Correct answer: Use should be personalized and approached with caution
Obesity management medications should generally be introduced after MBS when...
Correct answer: When there is a weight loss plateau or recurrent weight gain
Which of the following statements best reflects current expert opinion on revisional bariatric surgery?
Correct answer: It's complex and higher risk, so obesity management medications and endoscopy should be considered first
Results: out of 4
According to the IFSO consensus, when are obesity management medications most helpful after bariatric surgery?
Correct answer: When there is a weight loss plateau or recurrent weight gain following MBS
True or False: Obesity management medications are always recommended before MBS.
Correct answer: False – Preoperative use should be individualized, not routine
What is one major reason experts suggest using obesity management medications or endoscopy before revisional surgery?
Correct answer: Revisional surgery has higher complication risks
What is the key theme for future obesity treatment strategies, according to the consensus?
Correct answer: Develop personalized, sustainable obesity treatment and management approaches
- Cohen RV, Busetto L, Levinson R, Le Roux CW, Salminen P, Prager G; International Consensus on the Role of Obesity Management Medications in the Context of Metabolic Bariatric Surgery. International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Br J Surg. 2024 Nov 27;111(12):znae283. doi: 10.1093/bjs/znae283. PMID: 39612579.